India Revokes GSK Breast Cancer Drug Patent
The Indian government has revoked one of two patents held by GlaxoSmithKline Plc for its breast cancer drug Tykerb, a ruling that came four months after India's highest court raised the...To view the full article, register now.
Already a subscriber? Click here to view full article